Rare organisms should be considered as causative agents in refractory peritonitis cases.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Refractory peritonitis is defined as failure of effluent clearance after five days of appropriate antibiotics in peritoneal dialysis patients.
📊
Key Findings & Data:Although fungal and mycobacterial peritonitis are uncommon (approxi mately 15% of the cases), they are difficult to diagnose and treat.
💡
Conclusion & Impact:Rare organisms should be considered as causative agents in refractory peritonitis cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Refractory peritonitis is defined as failure of effluent clearance after five days of appropriate antibiotics in peritoneal dialysis patients. It is a reason for peritoneal dialysis failure. Although fungal and mycobacterial peritonitis are uncommon (approxi mately 15% of the cases), they are difficult to diagnose and treat. Herein, we report a case of peritonitis caused by two unusual pathogen, Candida guilliermondii and Mycobacterium avium complex, which probably reached the peritoneum via the vaginal route, in a long-term peritoneal dialysis patient with malnutrition. Rare organisms should be considered as causative agents in refractory peritonitis cases.
🔖
Cite This Article
SADİOĞLU, R. E., KARATAŞ, G., MEMİKOĞLU, K. O., KUTLAY, S., NERGİZOĞLU, G., ATEŞ, K. (2021). An Unusual Association of Candida Guilliermondii and Mycobacterium Avium Complex in a Peritoneal Dialysis Patient with Refractory Peritonitis. Turkish journal of nephrology (Online), Cilt: 30 - Sayı: 1, 80–82. https://ajindex.com/articles/374795
Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 2005; 45: 372-80. [Crossref] 2. Cho Y, Struijk DG. Peritoneal dialysis-related peritonitis: Atypical and resistant organisms. Semin Nephrol 2017; 37: 66-76. [Crossref] 3. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD Peritonitis Recommendations: 2016 update on prevention and treatment. Perit Dial Int 2016; 36; 481-508. [Crossref] 4. Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: A systematic review of reported cases. Nephrol Dial Transplant 2011; 27: 1639-44. [Crossref] 5. Auricchio S, Giovenzana ME, Pozzi M, Galassi A, Santorelli G, Dozio B, et al. Fungal peritonitis in peritoneal dialysis: A 34-year single centre evaluation. Clin Kidney J 2018; 11: 874-80. [Crossref] 6. Rubin J, Lin LM, Lewis R, Cruse J, Bower JD. Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 1983; 20: 140-4. 7. Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D, Papadimitriou M. Fungal peritonitis complicating peritoneal dialysis during an 11-year period: Report of 46 cases. Clin Infect Dis 2003; 36: 927-31. [Crossref] 8. Chow KM, Chow VC, Szeto CC. Indication for peritoneal biopsy in tuberculous peritonitis. Am J Surg 2003; 185: 567-73. [Crossref]